|
?:authorAffiliation
|
-
[\'Cancer Medicine Department, Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Biostatistics Department, Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Interdisciplinary Cancer Course Department, Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Haematology Department, Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Biopathology Department, Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Pharmacy Department, Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Imaging Department, Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Early Drug Development Department, Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Radiation Oncology Department, Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Paediatric Oncology Department, Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Gustave Roussy, Paris-Saclay University, Paris, France.\', \'Gustave Roussy, Paris-Saclay University, Paris, France. Fabrice.BARLESI@gustaveroussy.fr.\', \'Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France. Fabrice.BARLESI@gustaveroussy.fr.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}